CPT code 11982 represents the removal of a non‑biodegradable implant (capsule or pellet) used for controlled, long‑term drug delivery. This procedure is clinically important because such implants are common in chronic disease management and specialized therapies; proper coding ensures accurate tracking of procedural utilization and appropriate claims processing. Nationally, procedures like these affect hospital and ambulatory surgical volumes and have implications for device management and post‑implant care.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, and payer coverage considerations. The publication highlights benchmarks for utilization and reimbursement patterns, relevant policy updates affecting coding and claims adjudication, and coding nuances that influence billing practice.

This summary equips clinicians, billing professionals, and policy analysts with a clear reference to CPT code 11982, clarifying when the code applies and what stakeholders should consider when documenting and submitting claims. Data not available in the input are noted where applicable.